Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-05

Clinical Trial Update: Efficacy of Diuretics in Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating diuretic therapy for chronic kidney disease and end-stage renal disease was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unspecified diuretic

Snippet

Sponsor: Stanford University | Conditions: Chronic Kidney Disease, End Stage Renal Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-06-05